- Home
- DNTH vs JACK Comparison
DNTH vs JACK Comparison
Compare DNTH & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- JACK
- Stock Information
- Founded
- DNTH 2015
- JACK 1951
- Country
- DNTH United States
- JACK United States
- Employees
- DNTH N/A
- JACK N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- JACK Restaurants
- Sector
- DNTH Health Care
- JACK Consumer Discretionary
- Exchange
- DNTH Nasdaq
- JACK Nasdaq
- Market Cap
- DNTH 711.2M
- JACK 767.0M
- IPO Year
- DNTH N/A
- JACK 1987
- Fundamental
- Price
- DNTH $23.80
- JACK $40.73
- Analyst Decision
- DNTH Strong Buy
- JACK Buy
- Analyst Count
- DNTH 9
- JACK 18
- Target Price
- DNTH $46.43
- JACK $59.12
- AVG Volume (30 Days)
- DNTH 203.7K
- JACK 614.8K
- Earning Date
- DNTH 11-07-2024
- JACK 02-19-2025
- Dividend Yield
- DNTH N/A
- JACK 4.32%
- EPS Growth
- DNTH N/A
- JACK N/A
- EPS
- DNTH N/A
- JACK N/A
- Revenue
- DNTH $5,366,000.00
- JACK $1,571,306,000.00
- Revenue This Year
- DNTH $98.73
- JACK N/A
- Revenue Next Year
- DNTH N/A
- JACK $2.05
- P/E Ratio
- DNTH N/A
- JACK N/A
- Revenue Growth
- DNTH 51.41
- JACK N/A
- 52 Week Low
- DNTH $8.24
- JACK $38.12
- 52 Week High
- DNTH $33.77
- JACK $86.20
- Technical
- Relative Strength Index (RSI)
- DNTH 46.14
- JACK 34.66
- Support Level
- DNTH $22.59
- JACK $38.12
- Resistance Level
- DNTH $24.57
- JACK $50.22
- Average True Range (ATR)
- DNTH 1.49
- JACK 2.43
- MACD
- DNTH 0.04
- JACK -0.99
- Stochastic Oscillator
- DNTH 30.84
- JACK 21.17
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About JACK Jack In The Box Inc.
Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.